Shopping Cart
- Remove All
Your shopping cart is currently empty
Ginkgolic Acid
🥰Excellent
Catalog No. T6S2123Cas No. 22910-60-7
Alias Romanicardic acid, Ginkgolic acid I, Ginkgolic acid C15:1, Ginkgolic acid (15:1)
Ginkgolic Acid (Romanicardic acid) C15:1 represses curli genes and prophage genes in EHEC.
Ginkgolic Acid
🥰Excellent
Purity: 99.9%
Catalog No. T6S2123Alias Romanicardic acid, Ginkgolic acid I, Ginkgolic acid C15:1, Ginkgolic acid (15:1)Cas No. 22910-60-7
Ginkgolic Acid (Romanicardic acid) C15:1 represses curli genes and prophage genes in EHEC.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 20 mg | $100 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $60 | In Stock |
Bulk & Custom
Add to Cart
Questions
View MoreInhibitors Related to "Ginkgolic Acid"
Indole-3-carbinol
Indole-3-Methanol, I3C, 3-Indolemethanol
T2947700-06-1
Indole-3-carbinol (I3C), a naturally occurring, orally available cleavage product of the glucosinolate glucobrassicanin, inhibits NF-κB and IκBα kinase activation.
- $29
Size
QTY
NAE-IN-M22
Cited
NEDD8 inhibitor M22
T8816864420-54-2
NAE-IN-M22 (NEDD8 inhibitor M22) is a selective, potent and reversible inhibitor of NEDD8 activating enzyme (NAE). NAE-IN-M22 inhibits multiple cancer cell lines and induces apoptosis in A549 cells. NAE-IN-M22 also can inhibit tumor growth in vivo.
- $93
Size
QTY
CitedNutlin-3 Cited
Nutlin3
T2158548472-68-0
Nutlin-3 is an MDM2 antagonist that inhibits MDM2-p53 interaction (Ki=90 nM) and activates p53. Nutlin-3 binds preferentially to the p53-binding pocket of MDM2, leading to stabilization of p53 and activation of the p53 pathway. Nutlin-3 has antitumor activity.
- $31
Size
QTY
CitedNAcM-OPT
T53742089293-61-6
NAcM-OPT is a specific, reversible inhibitor targeting N-Acetyl-UBE2M interaction with DCN1 (IC50: 79 nM).
- $43
Size
QTY
NSC232003
T122611905453-18-0
NSC232003 is a highly potent and cell-permeable inhibitor of [UHRF1].
- $90
Size
QTY
PYZD-4409
T16699423148-78-1
PYZD-4409 is a selective UBA1 inhibitor with an IC50 of 20 μM. PYZD-4409 induces cell death in malignant cells and is preferentially cytotoxic to malignant cells over normal hematopoietic cells.
- $32
Size
QTY
PYR-41 Cited
PYR41, PYR 41
T6629418805-02-4
PYR-41 is the first cell-permeable inhibitor of ubiquitin-activating enzyme E1, with no activity at E2.
- $33
Size
QTY
CitedRG7112
RO5045337, RG-7112, RG 7112
T6965939981-39-2
RG7112 (RO5045337) (RO5045337) is an orally bioavailable and selective p53-MDM2 inhibitor.
- $41
Size
QTY
NSC697923
2-[(4-methylphenyl)sulfonyl]-5-nitrofuran
T6611343351-67-7In house
NSC-697923 (2-[(4-methylphenyl)sulfonyl]-5-nitrofuran), a potent inhibitor of UBE2N (ubiquitin-conjugating enzyme E2 N, Ubc13), exhibits its role in inducing cell death in neuroblastoma (NB) cells through two distinct mechanisms. In p53 wild-type NB cells, NSC-697923 promotes the nuclear importation of p53, thereby triggering cell death. Meanwhile, in p53 mutant NB cells, NSC-697923 activates the JNK-mediated apoptotic pathway, leading to cell death. Additionally, NSC-697923 inhibits DNA damage and NF-κB signaling, further contributing to its antitumor activity.
- $39
Size
QTY
Idasanutlin Cited
Ro 5503781, RG7388
T62541229705-06-9
Idasanutlin (Ro 5503781) (RG-7388) is an effective and specific p53-MDM2 inhibitor (IC50: 6 nM).
- $34
Size
QTY
CitedNavtemadlin
CS-1300, AMG232
TQ01271352066-68-2
Navtemadlin (AMG232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction (IC50: 0.6 nM). It binds to MDM2 with a Kd of 0.045 nM.
- $67
Size
QTY
Pevonedistat
Cited
MLN4924
T6332905579-51-3
Pevonedistat (MLN4924) is a potent and selective NEDD8 activating enzyme (NAE) inhibitor (IC50=4.7 nM) with therapeutic potential for myelodysplastic syndromes (MDS) and antitumor activity.
- $48
Size
QTY
CitedSelect Batch
Purity:99.9%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.Product Introduction
Bioactivity
Chemical Properties
| Description | Ginkgolic Acid (Romanicardic acid) C15:1 represses curli genes and prophage genes in EHEC. |
| Targets&IC50 | SUMOylation:3.0 μM (IC50) |
| Alias | Romanicardic acid, Ginkgolic acid I, Ginkgolic acid C15:1, Ginkgolic acid (15:1) |
| Molecular Weight | 346.5 |
| Formula | C22H34O3 |
| Cas No. | 22910-60-7 |
| Smiles | CCCCCC\C=C/CCCCCCCc1cccc(O)c1C(O)=O |
| Relative Density. | 1.014 g/cm3 |
Storage & Solubility Information
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 34.7 mg/mL (100.14 mM), Sonication is recommended. DMSO: 50 mg/mL (144.3 mM), Sonication is recommended.  | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 5% DMSO+95% Saline: 1.5 mg/mL (4.33 mM), In vivo: Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
| ||||||||||||||||||||||||||||||||||||
Sci Citations
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Ginkgolic Acid | purchase Ginkgolic Acid | Ginkgolic Acid cost | order Ginkgolic Acid | Ginkgolic Acid chemical structure | Ginkgolic Acid formula | Ginkgolic Acid molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.